Is NCT07276529 recruiting in Orlando, FL?

Yes, NCT07276529 is currently recruiting participants at its Orlando, FL location. This colorectal cancer clinical trial is actively enrolling qualified participants.

How do I join the colorectal cancer clinical trial in Orlando?

To join this clinical trial in Orlando, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Orlando clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Colorectal Cancer Clinical Trial in Orlando, FL

About This Colorectal Cancer Study in Orlando

The primary objective of this trial is to investigate the safety and effectiveness of the Flexagon 25mm SFM system plus OTOLoc when used to create a side-to-side Ileo-colic, Colo-colonic and side-to-side or end-to-side colorectal anastomoses in participants undergoing colon surgery. This will be evaluated via a composite safety/effectiveness endpoint of patient success defined as successful creation of the target anastomosis without placement procedure, device or target anastomosis related reoperation through 30 days.

Sponsor: GI Windows, Inc.

Who Can Participate

Inclusion Criteria

Aged 22 years or older at screening

Candidate for surgery requiring Right of Left Hemicolectomy or Sigmoidectomy or Low Anterior resection with cardiac/medical clearance for surgery

Able to understand and sign informed consent document

American Society of Anesthesiologists (ASA) score \< IV at time of procedure

All cancer patients must have completed chemotherapy ≥1 months prior to procedure

Lives, and intends to remain, within a 150-mile radius of study center for the duration of the study

Able to refrain from smoking during study follow-up period

Exclusion Criteria

Known or suspected allergy to silicone, nickel, titanium or Nitinol

BMI \> 55 kg/m2

Uncontrolled diabetes (defined as HbA1c \>10%)

Congenital or acquired anomalies of the GI tract, including atresia or malrotation that would inhibit passing of SFM magnet

Participants with an acute diagnosis of obstructed or perforated colon cancer at the time of the Screening Visit

Any documented conditions for which endoscopy and/or laparoscopy would be contraindicated or history of previous failed endoscopy that may suggest difficulty during endoscopic delivery of magnets

History of recurrent small bowel obstructions.

Coagulation deficiency not normalized by medical treatment or platelet count \<50,000/µL

Known moderate to severe renal disease (eGFR \< 44 milliliters per minute per 1.73m2) or ongoing dialysis

Hyperkalemia / hypercoagulability or prior Venus Thromboembolism / Pulmonary Embolism

Immunocompromised (e.g., active treatment for malignancies, hematologic malignancy, on immunosuppressive therapy, moderate or severe primary immunodeficiency, advanced or untreated HIV, active treatment with high-dose corticosteroids (i.e., 20 or more mg of prednisone or equivalent per day when administered for 2 or more weeks prior to surgery) or other immunosuppressive or immunomodulatory agents

Congestive heart failure with ejection fraction \<35% or clinically significant arrhythmia (any rhythm disturbances except sinus tachycardia, sinus bradycardia or a sinus rhythm with premature atrial or ventricular complexes)

Decompensated chronic obstructive lung disease

Active or suspected infection at the surgical site or a CDC Class 3/contaminated or Class 4/dirty-infected surgical wound.

Contraindication to general anesthesia

Breast-feeding, pregnant, or planning on becoming pregnant during the follow-up period

Currently participating or has participated in another clinical trial within the past 30 days and is receiving/has received an investigational drug, device, or biologic agent

Contraindication to general anesthesia

Participant is not appropriate for inclusion in the clinical trial, per the medical opinion of the Principal Investigator

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Orlando?

Yes, this clinical trial (NCT07276529) has an active research site in Orlando, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Colorectal Cancer Treatment Options in Orlando, FL

If you're searching for colorectal cancer treatment options in Orlando, FL, this clinical trial (NCT07276529) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Orlando research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colorectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all colorectal cancer clinical trials near you to find additional studies recruiting in your area.

Colorectal Cancer Clinical Trial in Orlando, FL

Expert Care in Orlando

IRB Approved

No-Cost Care

Apply for This Orlando Location

Why Participate?

Simple Process